Cargando…

How accurate is our prediction of biopsy outcome? PCA3-based nomograms in personalized diagnosis of prostate cancer

PURPOSE: The sensitivity and specificity of prostate-specific antigen (PSA) alone to select men for prostate biopsy remain suboptimal. This review aims at presenting a review of current prostate cancer (PCa) nomograms that incorporate Prostate Cancer Gene 3 (PCA3), which was designed to outperform P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salagierski, Maciej, Sosnowski, Marek, Schalken, Jack A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Urological Association 2012
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921800/ https://www.ncbi.nlm.nih.gov/pubmed/24578943 http://dx.doi.org/10.5173/ceju.2012.03.art1

Ejemplares similares

PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer Diagnosis
por: Salagierski, Maciej, et al.
Publicado: (2010)

Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
por: Matuszczak, Milena, et al.
Publicado: (2021)

PCA3 and PCA3-Based Nomograms Improve Diagnostic Accuracy in Patients Undergoing First Prostate Biopsy
por: Ruffion, Alain, et al.
Publicado: (2013)

Value of PCA3 to Predict Biopsy Outcome and Its Potential Role in Selecting Patients for Multiparametric MRI
por: Leyten, Gisele H. J. M., et al.
Publicado: (2013)

The role of a template-assisted cognitive transperineal prostate biopsy technique in patients with benign transrectal prostate biopsies: a preliminary experience
por: Salagierski, Maciej, et al.
Publicado: (2019)

External validation of extended prostate biopsy nomogram
por: Hrbáček, Jan, et al.
Publicado: (2015)

Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
por: Rubio-Briones, Jose, et al.
Publicado: (2015)

The need for a personalized approach for prostate cancer management
por: Sedelaar, JP Michiel, et al.
Publicado: (2015)

Resveratrol in prostate diseases
por: Salagierski, Maciej
Publicado: (2013)

A new predictor is comparable to the updated nomogram in predicting the intermediate- and high-risk prostate cancer but outperforms nomogram in reducing the overtreatment for the low-risk Pca
por: Wang, Hui, et al.
Publicado: (2019)

Radiofrequency Ablation: A Minimally Invasive Approach in Kidney Tumor Management
por: Salagierski, Maciej, et al.
Publicado: (2010)

An overview of prostate cancer (PCa) diagnosis: Potential role of miRNAs
por: Bilal, Muhammad, et al.
Publicado: (2022)

A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers
por: Matuszczak, Milena, et al.
Publicado: (2022)

The application of prostate artery embolization in the management of intractable prostate bleeding
por: Stężewska, Agata, et al.
Publicado: (2020)

Clinically significant prostate cancer (csPCa) detection with various prostate sampling schemes based on different csPCa definitions
por: Wang, Fei, et al.
Publicado: (2021)

Personalized Management in Low-Risk Prostate Cancer: The Role of Biomarkers
por: Dijkstra, Siebren, et al.
Publicado: (2012)

Performance of PCA3 and TMPRSS2:ERG urinary biomarkers in prediction of biopsy outcome in the Canary Prostate Active Surveillance Study (PASS)
por: Newcomb, Lisa F., et al.
Publicado: (2019)

Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells
por: Jeet, Varinder, et al.
Publicado: (2014)

MRI and Targeted Biopsy Essential Tools for an Accurate Diagnosis and Treatment Decision Making in Prostate Cancer
por: Samtani, Suraj, et al.
Publicado: (2021)

Clinical Significance of Peripheral Blood PCA3 Gene Expression in Early Diagnosis of Prostate Cancer
por: Chunhua, Lin, et al.
Publicado: (2018)

Active surveillance in prostate cancer management: where do we stand now?
por: Dragan, Jędrzej, et al.
Publicado: (2020)

Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients
por: Alshalalfa, Mohammed, et al.
Publicado: (2017)

Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)
por: Stephan, Carsten, et al.
Publicado: (2014)

Diagnosis accuracy of PCA3 level in patients with prostate cancer: a systematic review with meta-analysis
por: Qin, Zhiqiang, et al.
Publicado: (2020)

β-catenin as a prognostic factor for prostate cancer (PCa)
por: Nowicki, Andrzej, et al.
Publicado: (2012)

The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis
por: Luo, Yong, et al.
Publicado: (2014)

Three-dimensional ultrasound integrating nomogram and the blood flow image for prostate cancer diagnosis and biopsy: A retrospective study
por: Chen, Dong, et al.
Publicado: (2022)

Extraction of Prostatic Lumina and Automated Recognition for Prostatic Calculus Image Using PCA-SVM
por: Wang, Zhuocai, et al.
Publicado: (2011)

Electrochemical and optical detection and machine learning applied to images of genosensors for diagnosis of prostate cancer with the biomarker PCA3
por: Rodrigues, Valquiria C., et al.
Publicado: (2021)

Enzalutamide: targeting the androgen signalling pathway in metastatic castration‐resistant prostate cancer
por: Schalken, Jack, et al.
Publicado: (2015)

King’s Health Partners’ Prostate Cancer Biobank (KHP PCaBB)
por: Saifuddin, S. R., et al.
Publicado: (2017)

Identification of Plasma Glycosphingolipids as Potential Biomarkers for Prostate Cancer (PCa) Status
por: Snider, Ashley J., et al.
Publicado: (2020)

Improving RLRN Image Splicing Detection with the Use of PCA and Kernel PCA
por: Moghaddasi, Zahra, et al.
Publicado: (2014)

Letter to the Editor: Vienna Nomogram-Based Prostate Biopsy: Can It Be a Much Better Diagnostic Tool Than Other Conventional Prostate Biopsies?
por: Ho, Christopher Chee Kong, et al.
Publicado: (2014)

A novel nomogram predicting the risk of positive biopsy for patients in the diagnostic gray area of prostate cancer
por: Hou, Guang-Dong, et al.
Publicado: (2020)

Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
por: Schoots, Ivo G., et al.
Publicado: (2019)

MRI-Based Radiomics Nomogram for Predicting Prostate Cancer with Gray-Zone Prostate-Specific Antigen Levels to Reduce Unnecessary Biopsies
por: Zhang, Li, et al.
Publicado: (2022)

Development and Internal Validation of Novel Nomograms Based on Benign Prostatic Obstruction-Related Parameters to Predict the Risk of Prostate Cancer at First Prostate Biopsy
por: Cormio, Luigi, et al.
Publicado: (2018)

Contrast-enhanced ultrasound targeted versus conventional ultrasound guided systematic prostate biopsy for the accurate diagnosis of prostate cancer: A meta-analysis
por: Zhang, Ming, et al.
Publicado: (2022)

PCA-Based Incremental Extreme Learning Machine (PCA-IELM) for COVID-19 Patient Diagnosis Using Chest X-Ray Images
por: Kumar, Vinod, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oc0gl69t8vat8hshpe6a91fmpa